Aujesky et al randomized 344 people in 19 European emergency departments with low-risk pulmonary embolism to either be sent home with enoxaparin and warfarin within one day, or to be treated until therapeutic on warfarin in-hospital. They were then treated for 90 days. One of 171 home-treated patients developed recurrent VTE, while none of the 168 inpatients did. Two outpatients had major bleeding; none of the inpatients did. One patient in each group died within 90 days.
Outpatient treatment for pulmonary embolism
Outpatient treatment for pulmonary embolism
Outpatient treatment for pulmonary embolism
Aujesky et al randomized 344 people in 19 European emergency departments with low-risk pulmonary embolism to either be sent home with enoxaparin and warfarin within one day, or to be treated until therapeutic on warfarin in-hospital. They were then treated for 90 days. One of 171 home-treated patients developed recurrent VTE, while none of the 168 inpatients did. Two outpatients had major bleeding; none of the inpatients did. One patient in each group died within 90 days.
Comments on this post are for paid subscribers